Combination drug therapy for dyslipidemia.
Publication/Presentation Date
7-1-1999
Abstract
Effective treatment of dyslipidemia improves prognosis. Statin therapy has been documented to decrease the cardiovascular event rate in the setting of elevated low-density lipoprotein (LDL) cholesterol levels and coronary heart disease, but most patients are not treated to the target (LDL
Volume
1
Issue
1
First Page
44
Last Page
49
ISSN
1523-3804
Published In/Presented At
Alaswad, K., O'Keefe, J. H., Jr, & Moe, R. M. (1999). Combination drug therapy for dyslipidemia. Current atherosclerosis reports, 1(1), 44–49. https://doi.org/10.1007/s11883-999-0049-z
Disciplines
Medicine and Health Sciences
PubMedID
11122691
Department(s)
Department of Medicine
Document Type
Article
COinS